To identify new nonessential genes that affect genome integrity, we completed a screening for diploid mutant Saccharomyces cerevisiae strains that are sensitive to ionizing radiation (IR) and found 62 new genes that confer resistance. Along with those previously reported (Bennett et al., Nat. Genet. 29:426-434, 2001), these genes bring to 169 the total number of new IR resistance genes identified. Through the use of existing genetic and proteomic databases, many of these genes were found to interact in a damage response network with the transcription factor Ccr4, a core component of the CCR4-NOT and RNA polymerase-associated factor 1 (PAF1)-CDC73 transcription complexes. Deletions of individual members of these two complexes render cells sensitive to the lethal effects of IR as diploids, but not as haploids, indicating that the diploid G 1 cell population is radiosensitive. Consistent with a role in G 1 , diploid ccr4⌬ cells irradiated in G 1 show enhanced lethality compared to cells exposed as a synchronous G 2 population. In addition, a prolonged RAD9-dependent G 1 arrest occurred following IR of ccr4⌬ cells and CCR4 is a member of the RAD9 epistasis group, thus confirming a role for CCR4 in checkpoint control. Moreover, ccr4⌬ cells that transit S phase in the presence of the replication inhibitor hydroxyurea (HU) undergo prolonged cell cycle arrest at G 2 followed by cellular lysis. This S-phase replication defect is separate from that seen for rad52 mutants, since rad52⌬ ccr4⌬ cells show increased sensitivity to HU compared to rad52⌬ or ccr4⌬ mutants alone. These results indicate that cell cycle transition through G 1 and S phases is CCR4 dependent following radiation or replication stress.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.